Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance [4]

Diabetologia

Volumn 45, Issue 12, 2002, Pages 1739-1741

  Vozarova, B ^a   Stefan, N ^a   Hanson, R ^a   Lindsay, R S ^a   Bogardus, C ^a   Tataranni, P A ^a   Metz, C ^a   Bucala, R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AMERICAN INDIAN; ANTIGEN SPECIFICITY; BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET RESTRICTION; ETHNIC DIFFERENCE; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; LETTER; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SECRETORY GRANULE; BLOOD; PHYSIOLOGY;

EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INDIANS, NORTH AMERICAN; INSULIN RESISTANCE; MACROPHAGE MIGRATION-INHIBITORY FACTORS;

EID: 0036460731     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0896-4     Document Type: Letter

References (8)

1. Bloom BR, Bennett B “1966” Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82
2. Calandra T, Bernhagen J, Mitchell RA, Bucala R “1994” The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902
3. Waeber G, Calandra T, Roduit R et al. “1997” Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94:4782-4787
4. Yabunaka N, Nishihira J, Mizue Y et al. “2000” Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 23:256-258
5. Knowler WC, Pettitt DJ, Saad MF, Bennett PH “1990” Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab Rev 6:1-27
6. Calandra T, Echtenacher B, Roy DL et al. “2000” Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6:164-170
7. Lillioja S, Mott DM, Howard BV et al. “1988” Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225
8. Calandra T, Bucala R “1995” Macrophage migration inhibitory factor: A counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 47:39-51